Df-Life : Quality of Life in Patients With Fibrous Dysplasia
Df-Life
2 other identifiers
observational
149
1 country
1
Brief Summary
Fibrous dysplasia (FD) is a congenital skeletal disorder with multiple complications such as bone pain, fractures, deformities and nerve compression. Few quantitative studies have demonstrated its physical, mental and social negative impacts on patients but none have qualitatively evaluated their global quality of life. Our hypothesis is that a better knowledge of the quality of life of FD patients should allow to target the actions to be implemented to improve patients'care. The main objective of this qualitative research is therefore to investigate the quality of life of FD patients through 2 approaches: a qualitative study with focus groups interviews addressing several themes: self-image, psychological and emotional well-being, difficulties and adaptative strategies; and a quantitative study to measure the impact of FD on quality of life and on olfaction (sometimes affected by nerve compression due to the disease) using standardized questionnaires Short Form 36 (SF36) and Self-reported Mini Olfactory Questionnaire (SELF-MOQ).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2022
CompletedFirst Posted
Study publicly available on registry
June 6, 2022
CompletedStudy Start
First participant enrolled
November 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2023
CompletedMarch 22, 2024
March 1, 2024
Same day
June 2, 2022
March 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
FD Qualitative study: notions on quality of life
quality of life concepts that will emerge during group interviews.
during group interview (90 minutes)
FD Quantitative study: scores of quality of life and olfaction impairment
quality of life measured with SF36 score. Patients will answer to 11 questions. Olfaction impairment measured with SELF-MOQ olfaction score. Patients will answer to 14 questions
during 30 minutes
Study Arms (3)
FD qualitative study on quality of life.
FD patients (FD monostotic, FD polyostotic, with or without craniofacial damages) will be invited to attend a focus group on the following themes: symptoms, self-image, psychological and emotional well-being, difficulties in daily life and adaptative strategies. The focus-groups will be conducted in a semi-directive manner by a moderator and will be recorded; after a verbatim transcription of the focus group recordings, the data will be analyzed manually and with the help of a semantic analysis software. It will allow common notions about quality of life in FD to emerge. A demographic questionnaire will also be completed by the participants.
FD quantitative sudy on quality of life and olfaction.
Participants will receive two questionnaires to complete: the SF36 questionnaire (quality of life) and the SELF-MOQ questionnaire (olfaction impairment evaluation). Other data required for the study will be extracted from the medical record: age, weight, height, affected bone sites, Radiological/ biological activity data, sensorial deficit, medication. A demographic questionnaire will also be completed.
FD qualitative and quantitative study on quality of life and olfaction.
Patients will be invited to attend a focus group on quality of life (qualitative study) as described for group 1 and to complete questionnaires on quality of life and olfaction (quantitative study) as described for group 2
Interventions
Patients will be contacted and focus groups will be organized with 6 to 8 patients presenting different types of FD: monostotic, polyostotic, with or without craniofacial damage. Several focus-groups will be conducted with men only or women only. Patients will be led in a semi-directive manner by a moderator who will use an interview grid listing all the topics to be addressed: symptoms, self-image, psychological and emotional well-being, difficulties in daily life and adaptative strategies. The discussions will be recorded and transcribed verbatim. Data will be analyzed manually by 2 investigators and with the help of a semantic analysis software. The objective is to bring out common notions about the quality of life of patients, their psychological and emotional well-being, their difficulties in daily life and their coping strategies according to their condition. Differences or similarities between men and women will be investigated.
Participants will receive 3 questionnaires to complete: the SF36 questionnaire (quality of life), the SELF-MOQ questionnaire (olfaction evaluation) and a demographic questionnaire. Other data required for the study will be extracted from the medical record: age, weight, height, affected bone sites, Radiological/ biological activity data, sensorial deficit, medication. For each questionnaire, scores will be calculated and compared between the different FD patient populations according to sex, age and type of FD.
Eligibility Criteria
Primary care clinics: adults coming for consultation or hospitalization for fibrous dysplasia in Hopital Edouard Herriot rheumatology department in Lyon, France.
You may qualify if:
- Men and women
- years and more
- with Fibrous dysplasia
- Being followed in the rheumatology Department of the E. Herriot Hospital in Lyon.
- Non-opposition to take part in the study
- written consent to the audio recording of the discussions.
You may not qualify if:
- Legal incapacity or limited legal capacity
- Psychiatric or neurological condition that severely impairs comprehension
- Difficulty understanding spoken French
- Patients with another pathology with a major impact on quality of life
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Edouard Herriot Hospital - rheumatology
Lyon, 69003, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roland CHAPURLAT, Pr
Hospices Civils de Lyon
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2022
First Posted
June 6, 2022
Study Start
November 28, 2022
Primary Completion
November 28, 2022
Study Completion
May 2, 2023
Last Updated
March 22, 2024
Record last verified: 2024-03